Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells
Nabanita Mukherjee, Yan Lü, Adam R. Almeida, et al.
Oncotarget (2016) Vol. 8, Iss. 29, pp. 46801-46817
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
Erinna F. Lee, Tiffany J. Harris, Sharon Tran, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 5
Open Access | Times Cited: 152
MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
Arnold Bolomsky, Meike Vogler, Murat Cem Köse, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 130
BH3-mimetics: recent developments in cancer therapy
Paul A. Townsend, M. V. Kozhevnikova, Olivier Cexus, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 63
Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma
Dhiraj Kumar, Mahadeo Gorain, Gautam Kundu, et al.
Molecular Cancer (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 69
Selective targeting of antiapoptotic BCL‐2 proteins in cancer
Ahmet Can Timuçin, Hüveyda Başağa, Özgür Kütük
Medicinal Research Reviews (2018) Vol. 39, Iss. 1, pp. 146-175
Open Access | Times Cited: 69
MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells
Nabanita Mukherjee, Jenette Skees, Kaleb J. Todd, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 6
Open Access | Times Cited: 59
Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications
Monica Marzagalli, M. Raimondi, Fabrizio Fontana, et al.
Seminars in Cancer Biology (2019) Vol. 59, pp. 221-235
Open Access | Times Cited: 49
Targeting anti-apoptotic pathways eliminates senescent melanocytes and leads to nevi regression
Jaskaren Kohli, Ge Chen, Eleni Fitsiou, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 26
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade
Nabanita Mukherjee, Elizabeth Katsnelson, Tonya M. Brunetti, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 5
Regulatory role of sphingosine kinase and sphingosine-1-phosphate receptor signaling in progenitor/stem cells
Mah Lee Ng, Nagendra Sastry Yarla, Mario Menschikowski, et al.
World Journal of Stem Cells (2018) Vol. 10, Iss. 9, pp. 119-133
Open Access | Times Cited: 34
Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes
Faruck Lukmanul Hakkim, Hamid A. Bakshi, Shabia Shabir Khan, et al.
Oncotarget (2019) Vol. 10, Iss. 37, pp. 3472-3490
Open Access | Times Cited: 30
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma
Nabanita Mukherjee, Carol M. Amato, Jenette Skees, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2182-2182
Open Access | Times Cited: 25
New insights into the roles of antiapoptotic members of the Bcl-2 family in melanoma progression and therapy
Daniela Trisciuoglio, Donatella Del Bufalo
Drug Discovery Today (2021) Vol. 26, Iss. 5, pp. 1126-1135
Closed Access | Times Cited: 21
BH3 mimetics induce apoptosis independent of DRP-1 in melanoma
Nabanita Mukherjee, Andrew Strosnider, Bay Vagher, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 9
Open Access | Times Cited: 26
Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments
Nabanita Mukherjee, Adam R. Almeida, Katie Partyka, et al.
Oncotarget (2016) Vol. 7, Iss. 51, pp. 84594-84607
Open Access | Times Cited: 25
The Interplay between Tumour Microenvironment Components in Malignant Melanoma
Cornelia Amălinei, Adriana Grigoraş, Ludmila Lozneanu, et al.
Medicina (2022) Vol. 58, Iss. 3, pp. 365-365
Open Access | Times Cited: 13
PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer
Norman Fultang, Ashley M. Schwab, Sophia McAneny-Droz, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Transcriptome and Lipidomic Analysis Suggests Lipid Metabolism Reprogramming and Upregulating SPHK1 Promotes Stemness in Pancreatic Ductal Adenocarcinoma Stem-like Cells
Jinzhi Xu, Zhou Lina, Xiaojing Du, et al.
Metabolites (2023) Vol. 13, Iss. 11, pp. 1132-1132
Open Access | Times Cited: 6
Aldehyde dehydrogenase-positive melanoma stem cells in tumorigenesis, drug resistance and anti-neoplastic immunotherapy
Simin Zhang, Zhen Yang, Fazhi Qi
Molecular Biology Reports (2019) Vol. 47, Iss. 2, pp. 1435-1443
Closed Access | Times Cited: 18
Diphenhydramine induces melanoma cell apoptosis by suppressing STAT3/MCL-1 survival signaling and retards B16-F10 melanoma growth in vivo
Chi-Hung R. Or, Hong-Lin Su, Wee-Chyan Lee, et al.
Oncology Reports (2016) Vol. 36, Iss. 6, pp. 3465-3471
Open Access | Times Cited: 13
Targeting Mcl-1 inhibits survival and self-renewal of hepatocellular cancer stem-like cells
Huapeng Zhang, Gongquan Li, Guang‐Hui Chen, et al.
Clinics and Research in Hepatology and Gastroenterology (2018) Vol. 43, Iss. 3, pp. 292-300
Closed Access | Times Cited: 13
Enrichment of Melanoma Stem-Like Cells via Sphere Assays
Nabanita Mukherjee, Karoline A. Lambert, David A. Norris, et al.
Methods in molecular biology (2021), pp. 185-199
Open Access | Times Cited: 11
SASH1 S519N Variant Links Skin Hyperpigmentation and Premature Hair Graying to Dysfunction of Melanocyte Lineage
Karoline A. Lambert, Christopher M. Clements, Nabanita Mukherjee, et al.
Journal of Investigative Dermatology (2024) Vol. 145, Iss. 1, pp. 144-154.e3
Open Access | Times Cited: 1
Coptidis Rhizoma induces intrinsic apoptosis through BAX and BAK activation in human melanoma
Xiaoou Xu, Satoru Yokoyama, Yoshihiro Hayakawa, et al.
Oncology Reports (2017) Vol. 38, Iss. 1, pp. 538-544
Open Access | Times Cited: 12
Apoptosis induced by 9,11‑dehydroergosterol peroxide from Ganoderma�Lucidum mycelium in human malignant melanoma cells is Mcl‑1 dependent
Lin Zheng, Yum‐Shing Wong, Mumin Shao, et al.
Molecular Medicine Reports (2018)
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top